Patents by Inventor Atsuko Kamiya

Atsuko Kamiya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicinal composition for promoting synthesis of protoporphyrin IX
    Patent number: 9603928
    Abstract: The object of the present invention is to elucidate the resistance mechanism in infections that show resistance to ALA-PDT that uses a single ALA, and to provide a novel treatment method against these infections. The present invention provides a pharmaceutical composition for promoting protoporphyrin IX production in ALA-PDT for treating infection, characterized in that it comprises a substance that promotes the conversion from coproporphyrinogen III to protoporphyrin IX.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: March 28, 2017
    Assignees: SBI Pharmaceuticals Co., Ltd., Osaka City University
    Inventors: Masahiro Ishizuka, Urara Oto, Atsuko Kamiya, Kiwamu Takahashi, Tohru Tanaka, Toshiyuki Ozawa, Kuniyuki Morimoto, Keitaro Watanabe
  • FRATAXIN ENHANCER
    Publication number: 20160271090
    Abstract: The object of the present invention to provide an agent effective for treating and preventing e.g. a disease caused by reduction in frataxin production. The present invention provides a frataxin enhancer comprising 5-aminolevulinic acid (ALA) or a derivative thereof or salts thereof, as well as a therapeutic and/or prophylactic agent for a disease caused by reduction in frataxin production.
    Type: Application
    Filed: October 22, 2014
    Publication date: September 22, 2016
    Inventors: Taku CHIBAZAKURA, Tohru TANAKA, Fuminori ABE, Motowo NAKAJIMA, Atsuko KAMIYA, Naomi HAGA, Kiwamu TAKAHASHI
  • MEDICINAL COMPOSITION FOR PROMOTING SYNTHESIS OF PROTOPORPHYRIN IX
    Publication number: 20160136274
    Abstract: The object of the present invention is to elucidate the resistance mechanism in infections that show resistance to ALA-PDT that uses a single ALA, and to provide a novel treatment method against these infections. The present invention provides a pharmaceutical composition for promoting protoporphyrin IX production in ALA-PDT for treating infection, characterized in that it comprises a substance that promotes the conversion from coproporphyrinogen III to protoporphyrin IX.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 19, 2016
    Inventors: Masahiro Ishizuka, Urara Oto, Atsuko Kamiya, Kiwamu Takahashi, Tohru Tanaka, Toshiyuki Ozawa, Kuniyuki Morimoto, Keitaro Watanabe